Drug Research
First Time, Treatment For Acute ASPS Given The Go-Ahead
Atezolizumab (Tecentriq), a therapy for advanced alveolar soft tissue sarcoma (ASPS), has received FDA approval for the first time for adults and children two years of age and older who have ASPS that has migrated to other regions of...
Drug Research
FDA Drug Nods Dip To 37 In 2022 From 51- A Median Since 2017
The FDA recorded only 37 new drug approvals in 2022, down from an annual average of 51 since 2017. After having to retract its contentious 2021 approval of Biogen's Aduhelm Alzheimer's disease medication, has the FDA grown timid?
The incident...
Drug Research
New Technique Reveals Best Care For Breast Cancer Patients
A technique created by Karolinska Institutet researchers should be able to forecast whether a breast cancer patient will benefit from a specific treatment or not. According to a study that was published in PNAS, the cell-based approach has been...
News
Why Customer Experience is Key for Pharmacies in 2023
In a world where technology is meant to make life easier, one area it seems to fall short on is customer experience—especially in healthcare.
The many significant changes society has undergone in recent years have led to a decline in...
News
What does it take to manufacture oligonucleotides on a large scale?
Oligonucleotides are short, single or double-stranded fragments of DNA or RNA that can be used for therapeutic purposes. Originally, there was an emphasis on using this new drug modality for treating rare diseases, yet they have also shown great...
Drug Research
Novel Method To Stop Antibody From Blocking Transplant Cells
Researchers at UCSF have developed a novel, potentially life-saving technique that may prevent antibodies from prompting the immune system to reject specifically tailored therapeutic and transplant cells.
It has been particularly difficult to cure rejection caused by antibodies as opposed...
IT & Data Management
Technology Growth In The Biopharma Outsourcing Industry
Due to the fact that many contract manufacturing organisations (CMOs) are the only facilities able to produce vaccines and treatments in the enormous volumes required, outsourcing has become an essential component of the biopharmaceutical business. Other justifications for outsourcing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.